Editorial Board

Lawrence H. Boise
Cell death, BCL-2 family, apoptosis, pharmacology, therapeutic response, drug resistance

Robert Bristow
Radiobiology and radiation oncology, DNA damage and repair, therapeutic combinations with radiotherapy

Jason S. Carroll
Epigenetics and epigenomics, functional genomics, transcription, nuclear receptors and hormone receptors

Jose R. Conejo-Garcia
Immunobiology and immunotherapy, tumor immunology animal models, neoantigens, immune evasion and immunosuppression

Yves A. DeClerck
Tumor microenvironment, angiogenesis, metastasis, tumor cell interactions with stroma and extracellular matrix

Francesca Demichelis
Computational biology, cancer genomics and evolution, transcriptomics and gene expression, genetics of cancer risk

J. Alan Diehl
Cell cycle and checkpoints, cell signaling, protein turnover, metabolism, cellular stress responses

Heide L. Ford
Cell signaling, biochemistry, stemness and cellular differentiation factors, oncogenes and tumor suppressors, epithelial-to-mesenchymal transition, metastasis

W. Lee Kraus
Transcription factors, gene regulation and transcription, functional genomics, epigenetics and epigenomics, hormone signaling, PARPs and ADP-ribosylation

James J. Manfredi
p53 biology, cell death and apoptosis, cell cycle, gene regulation, drug mechanisms, tumor viruses

Steven B. McMahon
Oncogenes and tumor suppressors, gene regulation and transcription, cell signaling, cell cycle, cell death, epigenetics and chromatin biology

Mark A. Rubin
Structural and functional genomics, chromosomal translocations, gene amplifications and copy number variation, genomic instability, transcriptomics, precision oncology, lineage plasticity

Toshiyasu Taniguchi
DNA damage and repair, BRCA family, BRCA reversion mutations, genome maintenance, drug resistance, Fanconi anemia

Scott A. Tomlins
Comparative transcriptomics, molecular oncology, molecular pathology, structural and functional genomics, translational research, next-generation sequencing

Jean Y.J. Wang
Carcinogenesis, cell cycle, cell death, cell signaling, drug targets and mechanisms, drug resistance mechanisms, synthetic lethality

Ashani T. Weeraratna
Tumor microenvironment, metastasis, aging, cell signaling